CASP3 and precursor B-cell acute lymphoblastic leukemia: The increased activation of these pathways in αGAL-9 antibody-treated B-ALL is consistent with our observations of increased cell cycle progression (with accompanying DNA damage, Caspase 3 activation, and cell death).